Previous close | 9.48 |
Open | 9.67 |
Bid | 9.25 x 200 |
Ask | 9.55 x 200 |
Day's range | 9.20 - 9.67 |
52-week range | 3.81 - 17.70 |
Volume | |
Avg. volume | 294,208 |
Market cap | 556.406M |
Beta (5Y monthly) | 0.25 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
IGM Biosciences (IGMS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Over the last year, a good number of insiders have significantly increased their holdings in IGM Biosciences, Inc...
IGM Biosciences ( NASDAQ:IGMS ) Full Year 2023 Results Key Financial Results Net loss: US$246.4m (loss widened by 11...